# Targeted Potassium Levels for Prevention of ICD Therapy

> **NCT03833089** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Rigshospitalet, Denmark** · enrollment: 1200 (estimated)

## Conditions studied

- Ventricular Arrhythmias and Cardiac Arrest
- Implantable Defibrillator User
- Hypokalemia
- Hyperkalemia
- Ventricular Tachycardia
- Atrial Fibrillation

## Interventions

- **COMBINATION_PRODUCT:** Targeted serum potassium level

## Key facts

- **NCT ID:** NCT03833089
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-03-01
- **Primary completion:** 2025-05-09
- **Final completion:** 2035-04-01
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2025-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03833089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03833089, "Targeted Potassium Levels for Prevention of ICD Therapy". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03833089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*